Home » Authors » Trista Morrison

Trista Morrison

Articles

ARTICLES

Axcan Goes Private Through $1.3B TPG Acquisition Deal

Nov. 30, 2007

By Trista Morrison

NewCo News: Inviragen Moves CDC Vaccine Technology Toward Clinic

Nov. 29, 2007

By Trista Morrison

NewCo News: Inviragen Moves CDC Vaccine Technology Toward Clinic

Nov. 29, 2007

By Trista Morrison

Excaliard Snags $15.5M And Isis Fibrosis Drugs

Nov. 28, 2007

By Trista Morrison

Excaliard Snags $15.5M And Isis Fibrosis Drugs

Nov. 28, 2007

By Trista Morrison

Start-Up Alios Seeks Potent, Broad-Spectrum Antivirals

Nov. 27, 2007

By Trista Morrison

Start-Up Alios Seeks Potent, Broad-Spectrum Antivirals

Nov. 27, 2007

By Trista Morrison

Aegerion Again Seeking IPO, Filing To Raise $86M

Nov. 26, 2007

By Trista Morrison

Aegerion Again Seeking IPO, Filing To Raise $86M

Nov. 26, 2007

By Trista Morrison

Vaxart Series A To Advance Preclinical Vaccine Research

Nov. 16, 2007

By Trista Morrison

View All Articles by Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...